ACCP Beta-Lactam Antibiotic Dose Individualization in Acutely Ill Patients 2026 Consensus Guidance

from Clinical Guideline InSights · host Guideline Central

The 2026 Beta-Lactam Antibiotic Dose Individualization in Acutely Ill Patients consensus guidance, highlighting key recommendations and best practice statements across safety outcomes, monitoring for adverse events, and more. Beta-Lactam Antibiotic Dose Individualization in Acutely Ill Patients American College of Clinical PharmacyJuly 22, 2026Guideline Summary: https://www.guidelinecentral.com/guideline/5238093/ Full-Text: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70181

Episode metadata supplied by the publisher feed · Published Aug 7, 2026

Embed this episode

Attribution link and audio player

Ready to play

ACCP Beta-Lactam Antibiotic Dose Individualization in Acutely Ill Patients 2026 Consensus Guidance

0:00 7:29

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Clinical Guideline InSights?

This episode is 7 minutes long.

When was this Clinical Guideline InSights episode published?

This episode was published on August 7, 2026.

Can I download this Clinical Guideline InSights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!